Rush clinical trial provides new kidney cancer immunotherapy option – EurekAlert (press release)
EurekAlert (press release) |
Rush clinical trial provides new kidney cancer immunotherapy option
EurekAlert (press release) Blood samples of many cancer patients undergoing immunotherapy treatments at Rush are analyzed to measure immune biomarkers secreted by the tumor detected in peripheral blood mononuclear cells, a critical component of the immune system. |
